IRCT20200831048564N1 IRCT 2020-09-17 Mashhad University of Medical Sciences The effect of Tamsulosin and Solifenacin in the treatment of double J stent-related urinary symptoms Comparison of the effect of Tamsulosin, Solifenacin and their combination in the treatment of double J stent-related urinary symptoms in patients with ureteral stones 2019-09-23 anticipated 80 Complete https://irct.ir/trial/50627 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: A phase 3, single-blinded, sham-controlled randomized clinical trial (RCT) with the parallel-groups design of 80 patients. Simple individual randomization was done using sealed envelopes, Randomization description: simple individual randomization using sealed envelopes. In order to random allocation concealment by SNOSE method First, a random sequence assignment was created using the random number table method that created numbers from 00 to 99. Then based on the total sample size of the research, which is 80 people, 80 envelopes with aluminum wrappers (in order not to clarify the contents of the envelopes) were prepared and each of the random sequences created was recorded on a card and the cards were placed in envelopes. The order was placed. In order to maintain a random sequence on the outer surface of the envelopes, numbering was performed in the same way that A, B, C, and D drug groups were assigned in this envelopes. Accordingly, numbers between 00 to 24 were assigned to A group, number 25 to 49 B group, number 50 to 74 C group, and number 75 to 99 D group. Finally, the letter envelopes were glued and placed in a box, respectively. At the beginning of the registration of participants, based on the order of entry of the participants who met the inclusion criteria, one of the envelopes was opened and the assigned group of the participant was revealed, Blinding description: Research participants were blinded to the randomization. To maintain blindness, identical-looking medications and placebo without name were used. 3 lower urinary tract symptoms, ureteral stone. Intervention 1: Intervention group: 1; cap Tamsulosin 0.4 mg once daily for 2 weeks. Intervention 2: Intervention group: 2; Tab Solifenacin 5 mg once daily for 2 weeks. Intervention 3: Intervention group:3, cap including Tamsulosin 0.4 mg + Solifenacin 5 mg, once daily for 2 weeks. Intervention 4: Control group:Tab Placebo (identical-looking with the medication) once daily for 2 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is اطلاعات بیشتری وجود ندارد